Teleflex Inc
TFX122.630USD
-3.170-2.52%
Handelsschluss 09/19, 16:00（ET）Kurse um 15 Minuten verzögert
5.42BMarktkapitalisierung
28.24KGV TTM
mehr Informationen über Teleflex Inc Unternehmen
Teleflex Incorporated is a global provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company has four segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM (Original Equipment Manufacturer and Development Services). OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. Its OEM division includes the TFX Medical OEM, TFX OEM, Deknatel and HPC Medical brands, provides custom extrusions, micro-diameter film-cast tubing, diagnostic and interventional catheters, balloons and balloon catheters, film-insulated fine wire, coated mandrel wire, conductors, sheath/dilator introducers, and others. Its other brands include Arrow, LMA, Pilling, QuikClot, Rusch, UroLift, Weck and Barrigel.
Unternehmensinformationen
BörsenkürzelTFX
Name des UnternehmensTeleflex Inc
IPO-datumMar 17, 1980
CEOMr. Liam J. Kelly
Anzahl der mitarbeiter14100
WertpapierartOrdinary Share
GeschäftsjahresendeMar 17
Addresse550 E Swedesford Rd
StadtWAYNE
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl19087
Telefon16102256800
Websitehttps://www.teleflex.com/usa/en/#
BörsenkürzelTFX
IPO-datumMar 17, 1980
CEOMr. Liam J. Kelly
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+95.06%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Andere
117.40M
16.75%
Nach RegionUSD
Name
Umsatz
Anteil
Americas
475.72M
67.90%
EMEA
151.16M
21.57%
Asia Pacific
73.79M
10.53%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Vascular access
182.37M
26.03%
Interventional
137.56M
19.63%
Surgical
105.78M
15.10%
Anesthesia
86.59M
12.36%
Interventional urology
70.97M
10.13%
Andere
117.40M
16.75%
Aktionärsstatistik
Aktualisiert: Sun, Aug 17
Aktualisiert: Sun, Aug 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
13.45%
BlackRock Institutional Trust Company, N.A.
11.25%
The Vanguard Group, Inc.
10.86%
Janus Henderson Investors
9.39%
Atlanta Capital Management Company, L.L.C.
5.44%
Andere
49.61%
Aktionäre
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
13.45%
BlackRock Institutional Trust Company, N.A.
11.25%
The Vanguard Group, Inc.
10.86%
Janus Henderson Investors
9.39%
Atlanta Capital Management Company, L.L.C.
5.44%
Andere
49.61%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
59.80%
Investment Advisor/Hedge Fund
29.23%
Hedge Fund
8.39%
Pension Fund
1.68%
Research Firm
1.54%
Sovereign Wealth Fund
1.36%
Bank and Trust
0.67%
Individual Investor
0.34%
Family Office
0.09%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
2023Q1
1212
46.93M
99.93%
-1.70M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
T. Rowe Price Investment Management, Inc.
6.22M
14.07%
+43.64K
+0.71%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.36M
12.12%
+2.71M
+102.18%
Mar 31, 2025
The Vanguard Group, Inc.
5.07M
11.47%
-456.07K
-8.26%
Mar 31, 2025
Janus Henderson Investors
4.33M
9.79%
-933.48K
-17.75%
Mar 31, 2025
Atlanta Capital Management Company, L.L.C.
2.78M
6.29%
+73.14K
+2.70%
Mar 31, 2025
UBS Financial Services, Inc.
3.31M
7.5%
+3.09M
+1413.63%
Mar 31, 2025
State Street Global Advisors (US)
1.53M
3.46%
-531.22K
-25.79%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
867.86K
1.96%
+355.72K
+69.46%
Mar 31, 2025
Cooke & Bieler, L.P.
1.06M
2.39%
-21.03K
-1.95%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.02M
2.31%
-119.68K
-10.51%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
Invesco S&P SmallCap Health Care ETF
4.21%
First Trust Health Care Alphadex Fund
1.48%
SPDR S&P 600 Small Cap Value ETF
0.87%
iShares S&P Small-Cap 600 Value ETF
0.85%
iShares U.S. Medical Devices ETF
0.66%
iShares ESG Select Screened S&P Small-Cap ETF
0.45%
SPDR Portfolio Small Cap ETF (SPSM)
0.43%
iShares Core S&P Small-Cap ETF
0.42%
Invesco Zacks Mid-Cap ETF
0.32%
First Trust Mid Cap Value AlphaDEX Fund
0.31%
Mehr Anzeigen
Invesco S&P SmallCap Health Care ETF
Anteil4.21%
First Trust Health Care Alphadex Fund
Anteil1.48%
SPDR S&P 600 Small Cap Value ETF
Anteil0.87%
iShares S&P Small-Cap 600 Value ETF
Anteil0.85%
iShares U.S. Medical Devices ETF
Anteil0.66%
iShares ESG Select Screened S&P Small-Cap ETF
Anteil0.45%
SPDR Portfolio Small Cap ETF (SPSM)
Anteil0.43%
iShares Core S&P Small-Cap ETF
Anteil0.42%
Invesco Zacks Mid-Cap ETF
Anteil0.32%
First Trust Mid Cap Value AlphaDEX Fund
Anteil0.31%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
318.10M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
May 08, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 15, 2023 going ex on May 12, 2023
May 15, 2023
Jun 15, 2023
May 12, 2023
Feb 23, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2023 going ex on Mar 02, 2023
Mar 03, 2023
Mar 15, 2023
Mar 02, 2023
Oct 27, 2022
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2022 going ex on Nov 14, 2022
Nov 15, 2022
Dec 15, 2022
Nov 14, 2022
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
